Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |